Who are Hydrocortisone acetate and lidocaine hydrochloride's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hydrocortisone-acetate-and-lidocaine-hydrochloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Hydrocortisone acetate and lidocaine hydrochloride — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hydrocortisone acetate and lidocaine hydrochloride (Hydrocortisone acetate and lidocaine hydrochloride) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical corticosteroid and local anesthetic combination. Area: Dermatology.

marketed Topical corticosteroid and local anesthetic combination Glucocorticoid receptor (hydrocortisone); voltage-gated sodium channels (lidocaine) Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Hydrocortisone acetate and lidocaine hydrochloride (Hydrocortisone acetate and lidocaine hydrochloride) — Citius Pharmaceuticals, Inc.. Hydrocortisone acetate reduces inflammation and itching while lidocaine hydrochloride provides local anesthetic relief through topical application.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Hydrocortisone acetate and lidocaine hydrochloride TARGET	Hydrocortisone acetate and lidocaine hydrochloride	Citius Pharmaceuticals, Inc.	marketed	Topical corticosteroid and local anesthetic combination	Glucocorticoid receptor (hydrocortisone); voltage-gated sodium channels (lidocaine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical corticosteroid and local anesthetic combination class)

Citius Pharmaceuticals, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hydrocortisone acetate and lidocaine hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/hydrocortisone-acetate-and-lidocaine-hydrochloride. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab